These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17178941

  • 1. Meniett clinical trial: long-term follow-up.
    Gates GA, Verrall A, Green JD, Tucci DL, Telian SA.
    Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
    [Abstract] [Full Text] [Related]

  • 2. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
    Gates GA, Green JD, Tucci DL, Telian SA.
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
    [Abstract] [Full Text] [Related]

  • 3. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
    Gates GA, Green JD.
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
    [Abstract] [Full Text] [Related]

  • 4. The effect of the Meniett device in patients with Ménière's disease: long-term results.
    Dornhoffer JL, King D.
    Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Meniere's disease with the low-pressure pulse generator (Meniett device).
    Gates GA.
    Expert Rev Med Devices; 2005 Sep; 2(5):533-7. PubMed ID: 16293064
    [Abstract] [Full Text] [Related]

  • 6. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease.
    Barbara M, Monini S, Chiappini I, Filipo R.
    Acta Otolaryngol; 2007 Nov; 127(11):1136-41. PubMed ID: 17851896
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP, Din S, Atlas MD.
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [Abstract] [Full Text] [Related]

  • 8. Meniett device for Ménière's disease: use and compliance at 3 to 5 years.
    Mattox DE, Reichert M.
    Otol Neurotol; 2008 Jan; 29(1):29-32. PubMed ID: 18199955
    [Abstract] [Full Text] [Related]

  • 9. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [Abstract] [Full Text] [Related]

  • 10. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 11. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 12. Endolymphatic sac surgery for Ménière's disease: long-term results after primary and revision surgery.
    Wetmore SJ.
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1144-8. PubMed ID: 19015441
    [Abstract] [Full Text] [Related]

  • 13. Clinical long-term effects of Meniett pulse generator for Meniere's disease.
    Huang W, Liu F, Gao B, Zhou J.
    Acta Otolaryngol; 2009 Aug; 129(8):819-25. PubMed ID: 18923942
    [Abstract] [Full Text] [Related]

  • 14. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 15. Meniett therapy: rescue treatment in severe drug-resistant Ménière's disease?
    Boudewyns AN, Wuyts FL, Hoppenbrouwers M, Ketelslagers K, Vanspauwen R, Forton G, Van de Heyning PH.
    Acta Otolaryngol; 2005 Dec; 125(12):1283-9. PubMed ID: 16303675
    [Abstract] [Full Text] [Related]

  • 16. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
    Gürkov R, Filipe Mingas LB, Rader T, Louza J, Olzowy B, Krause E.
    J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
    [Abstract] [Full Text] [Related]

  • 17. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
    Barbara M, Consagra C, Monini S, Nostro G, Harguindey A, Vestri A, Filipo R.
    Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
    [Abstract] [Full Text] [Related]

  • 18. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
    Stokroos R, Olvink MK, Hendrice N, Kingma H.
    Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
    [Abstract] [Full Text] [Related]

  • 19. [Middle ear overpressure with Meniett in Menière disease: indications, results at short and middle terms in 53 cases].
    Faict H, Bouccara D.
    Rev Laryngol Otol Rhinol (Bord); 2007 Mar; 128(1-2):33-6. PubMed ID: 17633662
    [Abstract] [Full Text] [Related]

  • 20. Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
    Gates GA, Verrall AM.
    Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):863-7. PubMed ID: 16230587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.